Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
Status:
Completed
Trial end date:
2020-07-15
Target enrollment:
Participant gender:
Summary
This is a Phase 2 open-label efficacy, safety, and pharmacokinetic/pharmacodynamic (PK/PD)
study to evaluate oral vadadustat for the treatment of anemia in hemodialysis participants
converting from epoetin alfa therapy.